Veterinary Medicines Information website

COGLAMUNE

Not authorised
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
Download as PDF

Product identification

Medicine name:
COGLAMUNE
Active substance:
  • Clostridium perfringens, type A, alpha toxoid
  • Clostridium perfringens, type D, epsilon toxoid
  • Clostridium perfringens, type C, beta toxoid
Target species:
  • Cattle
  • Rabbit (for reproduction)
  • Pig (for reproduction)
  • Pig (for fattening)
  • Rabbit
  • Sheep
  • Goat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium perfringens, type A, alpha toxoid
    2.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type D, epsilon toxoid
    5.00
    international unit(s)
    /
    2.00
    millilitre(s)
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Rabbit (for reproduction)
      • All relevant tissues
        0
        day
    • Pig (for fattening)
      • All relevant tissues
        0
        day
    • Rabbit
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Goat
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI03AB
  • QI04AB01
  • QI08AB
  • QI09AB12
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • CZ Vaccines S.A.U.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/3350147 3/1983
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download